The Art of Waiting: Frictionless NEMO-Q Updates Are Coming To Improve Queuing Efficiencies


All system software eventually needs an upgrade. And, with NEMO-Q ready to serve up software enhancements for its legacy systems, Erik Berg, Sales Director at NEMO-Q, dropped by to let host Daniel Litwin in on what’s changing with this new rollout.

Berg said the new features are easy to identify, and users will notice the ease of use improvements right away.

“NEMO-Q recognized the need for customers to be able to configure the system to fit their needs, and the new software design does that,” he said.

The most significant shift in strategy is that NEMO-Q’s solutions are now web-based instead of client-based. This change allows for the versatility and ease-of-use customers expect today. Customers can expect to be able to utilize NEMO-Q on their smartphones and tablets with this upgrade.

“Ultimately, we haven’t changed the customer experience too much, but what we have done is improve those customers’ workflows and made life easier for them,” Berg said.

“By helping our customers, we’re helping their customers,” he said, noting that improvements in efficiencies should reduce customer queue wait-times.

For the latest news, videos, and podcasts in the Building Management Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook –
LinkedIn –

Follow us on social media for the latest updates in B2B!


NRF 2022 Retail's Big Show
What’s in the Shopping Cart for the 2022 National Retail Federation’s Big Show?
January 14, 2022
 In just a few short days, from January 16th through the 18th, the National Retail Federation will launch Retail’s Big Show in the shopping capital of the world, New York City. As retail Read more
Schools Struggle to Reach Their Education Technology Goals. Here’s Why and How To Fix It.
January 14, 2022
As we hit the two-year mark of the COVID-19 pandemic, the education sector continues to struggle in adjusting to virtual and hybrid education at scale. In 2020, McKinsey estimated that, due to COVID Read more
85% of Clinical Drug Trials Face Delays. What's the True Cost?
85% of Clinical Drug Trials Face Delays. What’s the True Cost?
January 14, 2022
  Clinical trials can save lives and provide new ways to treat disease. The industry estimates that 85% of all clinical trials face delays due to patient enrollment. Understanding that challenge Read more